Dendreon Gets OK For Sweetened $495M Sale To Valeant
A Delaware bankruptcy judge gave the nod Friday to Dendreon Corp.'s sale to a unit of Valeant Pharmaceuticals International Inc., approving a sweetened deal that increased the purchase price from $400...To view the full article, register now.
Already a subscriber? Click here to view full article